Published in Vaccine Weekly, May 6th, 2009
"The efficacy of genetic immunization was addressed by analysis of solid tumor outgrowth and the formation of metastases. Cell mediated immunity was determined by Cr-51-release cytotoxicity assays and adoptive lymphocyte transfer experiments. Genetic vaccination resulted in a persistent protection against the growth and metastasis of transplanted tumor cells....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.